Atherectomy Devices Market By Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices), By Disease Site (Coronary Artery Disease, Peripheral Artery Disease) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary and peripheral vessels. Perpetual rise in incidence of arterial blockages, particularly facilitated by the growth in geriatric population and cardiovascular diseases majorly contribute to the rise in the number of atherectomy procedures. Due to technological advancements, surgeons are replacing their existing atherectomy devices with novel solutions, as these replacements are found to be more efficient, safe and come with lesser complications.

The purpose of this research study titled ‘Atherectomy Devices Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global atherectomy devices market. This report presents and analyzes the major trends prevalent in the global Atherectomy Devices Market and the market size and forecast.

This report categorizes the global atherectomy devices market in terms of device type, disease site, and geographical distribution. Based on device type, the global atherectomy devices market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and laser atherectomy devices. Coronary artery disease and peripheral artery disease are the disease sites considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global atherectomy devices market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of device type, disease site, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global atherectomy devices market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the atherectomy devices market. The key players profiled in this report are Avinger, Inc., Boston Scientific Corporation, Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA Inc. (Volcano Corporation), Straub Medical AG, St. Jude Medical, LLC., and Terumo Interventional Systems.

Geographically, the global atherectomy devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Atherectomy Devices Market

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global atherectomy devices market. In North America and globally, the United States captures the largest revenue share. Higher prevalence of coronary and peripheral artery diseases, better awareness in patient population and physicians and evolved reimbursement scenario are the key factors driving the North America and Europe markets. Additionally, domicile of major market players thus ensuring early bird advantage also facilitate the market growth of these regions. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for atherectomy devices. Growing awareness, rapid development of healthcare infrastructure and perpetual growth in the prevalence of lifestyle-related diseases and obesity are the main driving factors for Asia Pacific atherectomy devices market.

The detailed regional classification of the global atherectomy devices market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany and Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)
Choose License Type
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58660
Report Format:   PDF
Pages:   120
Rating:    4.2 (40)
Connect With Us
24/7 Research Support